Exercise of the Manufacturing License Sample Clauses

Exercise of the Manufacturing License. Chugai may exercise any ------------------------------------- of its rights under the Manufacturing License, only to the extent expressly permitted in Section 6.11 above. In such event, CTIT shall provide to Chugai, within no later than ***, copies of all documentation within CTIT's control that is reasonably necessary for Chugai to manufacture the Product. ________________________ * The information above marked by *** has been omitted by a request for confidential treatment. The ommitted portion has been separately filed with the Commission.
Sample 1
AutoNDA by SimpleDocs
Exercise of the Manufacturing License. Allergan agrees to exercise any of its rights under the Manufacturing License, only to the extent expressly permitted in Section 2.7.3 above. In such event, Ista shall provide to Allergan, no later than within thirty (30) calendar days, copies of all documentation within Ista's control that is reasonably necessary for Allergan to manufacture (or have manufactured) Finished Product, and shall cooperate with Allergan to establish alternative supply, including sources of materials. In the event that Allergan has Finished Product manufactured by a Third Party, such Third Party shall enter into a confidentiality agreement with Ista to protect against the unauthorized use and disclosure of Ista's Confidential Information.
Sample 1
Exercise of the Manufacturing License. BML agrees not to exercise any of its rights under the Manufacturing License except to the extent expressly permitted in this Section 9.10.2 above. In such event, TWT shall provide to BML copies of all documentation within TWT's control that is reasonably necessary for BML to manufacture (or have manufactured) Collaboration Products, and shall reasonably cooperate with BML to establish alternative supply, including sources of materials. BML may exercise its right to have Collaboration Products manufactured in accordance with this Section 9.10.2 through a single third party contract manufacturer subject to TWT's approval, not to be unreasonably withheld; and provided that such third party manufacturer (i) enters into a confidentiality agreement with TWT to protect against the unauthorized use and disclosure of Confidential Information of TWT and (ii) agrees to provide Collaboration Products only to BML for its use.
Sample 1
Exercise of the Manufacturing License 
Sample 1

Related to Exercise of the Manufacturing License

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Manufacturing Rights Manufacturing Rights will be governed by Attachment 6.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Commercialization Diligence Upon receipt of the Marketing Authorization for a Licensed Product in the Field in a given Region in the Territory, Lian (directly, or through its Affiliates, Sublicensees or contractors) will use Commercially Reasonable Efforts to Commercialize such Licensed Product in the Field in such Region in the Territory. Lian will have sole decision-making authority and discretion with respect to Commercializing the Licensed Product in the Field in the Territory. [***].

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!